Published in J Clin Pharmacol on April 01, 1995
Temporary cardiac pacemaker in the treatment of junctional rhythm and hypotension due to imipramine intoxication. Pediatr Cardiol (2011) 0.75
Heart rate variability in children with tricyclic antidepressant intoxication. Cardiol Res Pract (2013) 0.75
Electrocardiograms changes in children with functional gastrointestinal disorders on low dose amitriptyline. World J Gastroenterol (2014) 0.75
Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther (2007) 2.17
Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations. Clin Pharmacokinet (1992) 1.94
Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med (2000) 1.80
Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet (1999) 1.79
Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet (1999) 1.67
Acute hepatic failure associated with the use of sodium valproate. N Engl J Med (1979) 1.55
Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48
Clinical pharmacology: a discipline called to action for maternal and child health. Clin Pharmacol Ther (2007) 1.46
Application of pharmacokinetics in the diagnosis of chemical abuse in Münchausen syndrome by proxy. Clin Pediatr (Phila) (1988) 1.38
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics (1999) 1.36
Acetaminophen overdose with therapeutic intent. J Pediatr (1998) 1.29
Immediate action needed to improve labeling of prescription drugs for pediatric patients. Ann Pharmacother (1997) 1.25
Developmental pharmacodynamics of cyclosporine. Clin Pharmacol Ther (1999) 1.22
Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother (1985) 1.20
Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. J Pediatr (1982) 1.19
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. Clin Pharmacol Ther (2007) 1.18
Treatment of neonatal hypertension with enalaprilat. J Pediatr (1990) 1.17
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". Clin Pharmacol Ther (2000) 1.12
Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am (1997) 1.12
Efficacy, disposition and pharmacodynamics of aspirin, acetaminophen and choline salicylate in young febrile children. Ther Drug Monit (1982) 1.12
Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J Pediatr (1991) 1.10
Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol (1992) 1.06
Treatment of pain with gabapentin in a neonate. Pediatrics (2001) 1.05
The neurotoxicity of cyclotrimethylenetrinitramine (RDX) in a child: a clinical and pharmacokinetic evaluation. J Toxicol Clin Toxicol (1986) 1.01
Cocaine: clinical pharmacology and toxicology. J Pediatr (1989) 1.01
Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther (1998) 0.99
Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine. Drug Metab Dispos (1999) 0.99
Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. . J Clin Pharmacol (2001) 0.98
Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther (2001) 0.97
Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol (2002) 0.96
Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults. J Clin Pharmacol (2001) 0.96
Single-dose pharmacokinetics of imipenem in children. J Pediatr (1984) 0.95
Breakthrough sepsis in macrolide-resistant pneumococcal infection. Pediatr Infect Dis J (1996) 0.94
Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin Pharmacol Ther (1999) 0.93
The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration. J Clin Pharmacol (2001) 0.92
Nifedipine poisoning in a child. Pediatrics (1990) 0.92
Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila) (2001) 0.91
The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J Toxicol Clin Toxicol (1998) 0.91
Interpreting pharmacogenetic data in the developing neonate: the challenge of hitting a moving target. Clin Pharmacol Ther (2012) 0.90
Gentamicin pharmacokinetics in neonates with patent ductus arteriosus. Crit Care Med (1997) 0.89
Histamine: new thoughts about a familiar mediator. Clin Pharmacol Ther (2010) 0.89
Integrated pharmacokinetic-pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children. J Pharmacokinet Biopharm (1998) 0.88
Age-related differences in digoxin toxicity and its treatment. Drug Saf (1992) 0.87
Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping. Pharmacogenetics (1998) 0.87
Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections. Antimicrob Agents Chemother (1986) 0.87
Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr (1992) 0.86
Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis. J Pediatr (1985) 0.86
The clearance and metabolism of biotin administered intravenously to pigs in tracer and physiologic amounts is much more rapid than previously appreciated. J Nutr (2001) 0.85
Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents. Clin Pharmacol Ther (2001) 0.84
Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol (1996) 0.84
Effect of age and renal function on cefonicid pharmacokinetics. Antimicrob Agents Chemother (1989) 0.83
Antimicrobial therapy for pediatric patients. Pediatr Clin North Am (1989) 0.83
Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food. Antimicrob Agents Chemother (1998) 0.83
Clinical pharmacology as a foundation for translational science. Clin Pharmacol Ther (2011) 0.83
Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children. Antimicrob Agents Chemother (1995) 0.82
Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping. Clin Pharmacol Ther (1998) 0.82
Absence of a pharmacokinetic interaction between chloramphenicol and acetaminophen in children. J Pediatr (1985) 0.82
Serum sickness-like reactions associated with cefprozil therapy. J Pediatr (1994) 0.82
Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol (1998) 0.81
Bromism: intoxication from a rare anticonvulsant therapy. Pediatr Emerg Care (1997) 0.81
Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients. J Clin Pharmacol (1998) 0.81
Adverse pulmonary responses to aspirin and acetaminophen in chronic childhood asthma. Pediatrics (1983) 0.81
Microanalytical high-performance liquid chromatography assay for cefpirome (HR 810) in serum. Antimicrob Agents Chemother (1988) 0.81
Pharmacokinetics of high dose thiotepa in children undergoing autologous bone marrow transplantation. Bone Marrow Transplant (1992) 0.80
Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation. J Clin Pharmacol (2002) 0.80
Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms. Drug Metab Dispos (2001) 0.80
Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clin Pharmacol Ther (2001) 0.80
Effect of extracorporeal membrane oxygenation on tobramycin pharmacokinetics in sheep. Crit Care Med (1992) 0.80
Phenytoin protein binding in pediatric patients with acute traumatic injury. Crit Care Med (1990) 0.79
Effects of IGF-I on the synthesis and processing of glycosaminoglycan in cultured chick chondrocytes. Acta Endocrinol (Copenh) (1988) 0.79
Pharmacokinetics and pharmacodynamics of famotidine in infants. J Clin Pharmacol (1998) 0.79
Rifapentine pharmacokinetics in adolescents. Pediatr Infect Dis J (1999) 0.79
Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes. J Clin Pharmacol (1995) 0.79
Acetaminophen toxicity in children: diagnostic confirmation using a specific antigenic biomarker. J Clin Pharmacol (1996) 0.79
GC-MS determination of amphetamine and methamphetamine in human urine for 12 hours following oral administration of dextro-methamphetamine: lack of evidence supporting the established forensic guidelines for methamphetamine confirmation. J Anal Toxicol (1996) 0.79
Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults. J Clin Pharmacol (1999) 0.79
Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children. J Clin Endocrinol Metab (1998) 0.79
Renal clearance of imipenem in children. Eur J Clin Microbiol (1984) 0.78
Bioavailable copper complexes offer a physiologic approach to treatment of chronic diseases. Adv Exp Med Biol (1989) 0.78
Use of continuous infusion of pralidoxime for treatment of organophosphate poisoning in children. J Pediatr (1990) 0.78
Fluorescein phototoxicity in a premature infant. J Pediatr (1985) 0.77
Dextromethorphan in nonketotic hyperglycinaemia: metabolic variation confounds the dose-response relationship. J Inherit Metab Dis (1997) 0.77
Characterization of delayed liquid gastric emptying in children by the (13)C-acetate breath test. J Breath Res (2009) 0.77
Paediatric labelling requirements. Implications for pharmacokinetic studies. Clin Pharmacokinet (1994) 0.77
Reduced activities of cytochrome P450 1A2 and xanthine oxidase in children with growth hormone deficiency. Clin Pharmacol Ther (2008) 0.77
Carbamazepine intoxication following the use of erythromycin in children. Pediatr Infect Dis J (1987) 0.77
Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design. Clin Pharmacol Ther (2012) 0.77
Gentamicin disposition and effect on development of renal function in the very low birth weight infant. Dev Pharmacol Ther (1984) 0.76
Alteration of phenytoin binding by glycosylation of albumin in IDDM. Diabetes (1987) 0.76
Effect of glycated albumin on phenytoin binding in elderly patients with type II diabetes mellitus. Pharmacotherapy (1990) 0.76
The challenges of delivering pharmacogenomics into clinical pediatrics. Pharmacogenomics J (2002) 0.76
The use of glucagon in nifedipine poisoning complicated by clonidine ingestion. Pediatr Emerg Care (1997) 0.76
Appearance of ranitidine in breast milk following multiple dosing. Clin Pharm (1985) 0.76
Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience. Diagn Microbiol Infect Dis (1989) 0.76
Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data. Dev Pharmacol Ther (1991) 0.76
Pharmacokinetics and pharmacodynamics of famotidine in children. J Clin Pharmacol (1996) 0.76
Endotracheal tobramycin in gram-negative pneumonitis. Drug Intell Clin Pharm (1988) 0.75
Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin. Antimicrob Agents Chemother (2000) 0.75
Adolescent pharmacology: a pertinent issue of medicine as opposed to medicines. Clin Pharmacol Ther (2008) 0.75